John Casey - Profile and Investment Details

Investor Profile

John Casey is a Venture Capital based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods, Inzen Therapeutics, Ohana Biosciences, T2 Biosystems, Tangent Medical Technologies, Kaleido BioSciencesPermeon Biologics, Kovio, Oasys Water, Editas Medicine, Tessera Therapeutics, Ring Therapeutics, Moderna Therapeutics, Omega Therapeutics, Cygnal Therapeutics, Sana Biotechnology, Seres Therapeutics, Agios Pharmaceuticals, Red Rock Biofuels, Tarveda Therapeutics, Receptos, Repertoire Immune Medicines, Generate Biomedicines, Codiak Biosciences, BlackDuck, Polatis, Seventh Sense Biosystems, Sigilon Therapeutics, Boragen, TARIS Biomedical, TransMedics, Selecta Biosciences, Quanterix, Visterra, Sesen Bio, Inc., CiBO Technologies, medidametrics, Rubius Therapeutics, Axcella, Senda Biosciences, Foghorn Therapeutics, Evelo Biosciences, MIT $100K Entrepreneurship Competition, Inari, Joule Unlimited Technologies, Cellarity, WikiCell Designs, Avedro, Indigo, EcoSense Lighting, Valo Health, Invaio Sciences, . Over time, John Casey has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether John Casey is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Women Founded, Life Science, Biotechnology, Hispanic / Latinx Founded, Clean Technology, Groceries, Research, Agriculture, Oil and Gas, Medical, B2B, Therapeutics, Online Marketplace, Pharmaceuticals may find it worthwhile to explore potential connections with John Casey, as their portfolio suggests a familiarity and interest in this area.

Understanding John Casey’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.